These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 21284404

  • 1. Identification of small-molecule inhibitors against human leukocyte antigen-death receptor 4 (HLA-DR4) through a comprehensive strategy.
    Liu Z, Li B, Li X, Zhang L, Lai L.
    J Chem Inf Model; 2011 Feb 28; 51(2):326-34. PubMed ID: 21284404
    [Abstract] [Full Text] [Related]

  • 2. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
    Zhou Q, Cheng YJ, Li ZG, Zhou WH, Lu HS.
    Zhonghua Yi Xue Za Zhi; 2003 Sep 10; 83(17):1505-9. PubMed ID: 14521731
    [Abstract] [Full Text] [Related]

  • 3. An HLA-binding-motif-aided peptide epitope library: a novel library design for the screening of HLA-DR4-restricted antigenic peptides recognized by CD4+T cells.
    Tana T, Kamikawaji N, Savoie CJ, Sudo T, Kinoshita Y, Sasazuki T.
    J Hum Genet; 1998 Sep 10; 43(1):14-21. PubMed ID: 9609993
    [Abstract] [Full Text] [Related]

  • 4. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.
    Rosloniec EF, Brand DD, Myers LK, Esaki Y, Whittington KB, Zaller DM, Woods A, Stuart JM, Kang AH.
    J Immunol; 1998 Mar 15; 160(6):2573-8. PubMed ID: 9510154
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides.
    Li X, Li R, Li Z.
    Tissue Antigens; 2006 Jan 15; 67(1):45-52. PubMed ID: 16451200
    [Abstract] [Full Text] [Related]

  • 6. [Proliferation of type II collagen specific T cell response and antibody formation in rheumatoid arthritis and their relations to HLA-DR4].
    Zhou Q, Li X, Li R, Zheng WY, Li ZG.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 16; 85(6):370-3. PubMed ID: 15854524
    [Abstract] [Full Text] [Related]

  • 7. The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice.
    Wang D, Hill JA, Cairns E, Bell DA.
    J Autoimmun; 2002 Mar 16; 18(2):95-103. PubMed ID: 11908942
    [Abstract] [Full Text] [Related]

  • 8. Altered collagen II peptides inhibited T-cell activation in rheumatoid arthritis.
    Li R, Li X, Li Z.
    Clin Immunol; 2006 Mar 16; 118(2-3):317-23. PubMed ID: 16343992
    [Abstract] [Full Text] [Related]

  • 9. Humanized transgenic mice expressing HLA DR4-DQ3 haplotype: reconstitution of phenotype and HLA-restricted T-cell responses.
    Chen Z, de Kauwe AL, Keech C, Wijburg O, Simpfendorfer K, Alexander WS, McCluskey J.
    Tissue Antigens; 2006 Sep 16; 68(3):210-9. PubMed ID: 16948641
    [Abstract] [Full Text] [Related]

  • 10. The inhibitory effect of altered collagen II peptide on HLA-DRB1-restricted T-cell activation.
    Cheng YJ, Zhou Q, Li ZG.
    Scand J Immunol; 2005 Mar 16; 61(3):260-5. PubMed ID: 15787743
    [Abstract] [Full Text] [Related]

  • 11. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
    Feitsma AL, van der Voort EI, Franken KL, el Bannoudi H, Elferink BG, Drijfhout JW, Huizinga TW, de Vries RR, Toes RE, Ioan-Facsinay A.
    Arthritis Rheum; 2010 Jan 16; 62(1):117-25. PubMed ID: 20039411
    [Abstract] [Full Text] [Related]

  • 12. T84-intestinal epithelial exosomes bear MHC class II/peptide complexes potentiating antigen presentation by dendritic cells.
    Mallegol J, Van Niel G, Lebreton C, Lepelletier Y, Candalh C, Dugave C, Heath JK, Raposo G, Cerf-Bensussan N, Heyman M.
    Gastroenterology; 2007 May 16; 132(5):1866-76. PubMed ID: 17484880
    [Abstract] [Full Text] [Related]

  • 13. Modeling ligand-receptor interaction for some MHC class II HLA-DR4 peptide mimetic inhibitors using several molecular docking and 3D QSAR techniques.
    Wei HY, Tsai KC, Lin TH.
    J Chem Inf Model; 2005 May 16; 45(5):1343-51. PubMed ID: 16180911
    [Abstract] [Full Text] [Related]

  • 14. Influenza virus haemagglutinin-derived peptides inhibit T-cell activation induced by HLA-DR4/1 specific peptides in rheumatoid arthritis.
    Li X, Li R, Li Z.
    Clin Exp Rheumatol; 2006 May 16; 24(2):148-54. PubMed ID: 16762149
    [Abstract] [Full Text] [Related]

  • 15. Recognition of altered self major histocompatibility complex molecules modulated by specific peptide interactions.
    Nepom GT, Ou D, Lybrand TP, DeWeese C, Domeier ME, Buckner JH, Mitchell LA, Tingle AJ.
    Eur J Immunol; 1996 Apr 16; 26(4):949-52. PubMed ID: 8625994
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Structure-based discovery of nonpeptidic small organic compounds to block the T cell response to myelin basic protein.
    Koehler NK, Yang CY, Varady J, Lu Y, Wu XW, Liu M, Yin D, Bartels M, Xu BY, Roller PP, Long YQ, Li P, Kattah M, Cohn ML, Moran K, Tilley E, Richert JR, Wang S.
    J Med Chem; 2004 Oct 07; 47(21):4989-97. PubMed ID: 15456243
    [Abstract] [Full Text] [Related]

  • 18. [Relationship between HLA-DR4/1 subtypes and T cell response to influenza virus hemagglutinin or anti-HA308-317 antibodies in rheumatoid arthritis].
    Li X, Li R, Li ZG.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 15; 88(27):1881-3. PubMed ID: 19039998
    [Abstract] [Full Text] [Related]

  • 19. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation.
    Chen YZ, Matsushita S, Nishimura Y.
    J Immunol; 1996 Nov 01; 157(9):3783-90. PubMed ID: 8892606
    [Abstract] [Full Text] [Related]

  • 20. Disease-stage variance in functional CD4(+) T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes.
    Warrino DE, Olson WC, Knapp WT, Scarrow MI, D'Ambrosio-Brennan LJ, Guido RS, Edwards RP, Kast WM, Storkus WJ.
    Clin Cancer Res; 2004 May 15; 10(10):3301-8. PubMed ID: 15161683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.